Individualised dosing of commonly used anti-cancer agents
Pharmacogenomics guided adaptive dosing of fluoropyrimidines
Date
30 Sep 2019Session
Individualised dosing of commonly used anti-cancer agentsPresenters
Hans GelderblomAuthors
H. GelderblomAuthor affiliations
- Medical Oncology Dept, Leids Universitair Medisch Centrum (LUMC), 2333 ZA - Leiden/NL
Resources
Resources from the same session
Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKIs)
Presenter: Markus Joerger
Session: Individualised dosing of commonly used anti-cancer agents
Resources:
Slides
Webcast
Optimising dosing of I-O agents
Presenter: Emiliano Calvo
Session: Individualised dosing of commonly used anti-cancer agents
Resources:
Slides
Webcast
Introduction
Presenter: Emiliano Calvo
Session: Individualised dosing of commonly used anti-cancer agents
Resources:
Slides
Webcast
Drug-food interactions
Presenter: Marzia Del Re
Session: Individualised dosing of commonly used anti-cancer agents
Resources:
Slides
Webcast
Drug-drug interactions: Focus on acid-suppressive agents
Presenter: Ron Mathijssen
Session: Individualised dosing of commonly used anti-cancer agents
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Ron Mathijssen
Session: Individualised dosing of commonly used anti-cancer agents
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.